acl's phase 2 was open label, their phase 3 wasn't.
neu's phase 2 was double blinded with a patient group that was very unlikely to be effected by the placebo effect.
In neu's phase 2 the placebo patients showed little alteration. The lower dose showed improvement and the higher dose showed good improvement. Just what one want's to see.
There's still risk, but I agree that acl and neu are world's apart.
- Forums
- ASX - By Stock
- NEU
- A possibility worth worth contemplating
A possibility worth worth contemplating, page-11
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.91 |
Change
-1.230(5.56%) |
Mkt cap ! $2.663B |
Open | High | Low | Value | Volume |
$22.06 | $22.11 | $20.63 | $5.767M | 270.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 299 | $20.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.91 | 11 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 313 | 20.900 |
4 | 163 | 20.890 |
7 | 285 | 20.880 |
3 | 648 | 20.870 |
4 | 864 | 20.860 |
Price($) | Vol. | No. |
---|---|---|
20.920 | 105 | 7 |
20.930 | 258 | 7 |
20.940 | 145 | 2 |
20.950 | 157 | 3 |
20.960 | 144 | 2 |
Last trade - 14.23pm 18/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |